Entrada Therapeutics, Inc.EE

Entrada Therapeutics, Inc.

10.81USDR
−0.01−0.09%
At close at Mar 14, 20:23 GMT
USD
No trades
See on Supercharts

Price target

24.33RUSD+13.52+125.10%
The 3 analysts offering 1 year price forecasts for Entrada Therapeutics, Inc. have a max estimate of 30.00 and a min estimate of 20.00.

Analyst rating

Based on 5 analysts giving stock ratings to Entrada Therapeutics, Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
5
Buy
0
Hold
0
Sell
0
Strong sell
0

EPS

Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
‪−1.60‬
‪−0.80‬
‪0.00‬
‪0.80‬
‪1.60‬
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
‪−0.78‬
‪1.02‬
‪−0.29‬
‪0.68‬
‪1.55‬
‪−0.35‬
‪0.03‬
Estimate
‪−0.69‬
‪−0.73‬
‪−0.17‬
‪−0.59‬
‪0.36‬
‪−0.73‬
‪−0.67‬
‪−0.73‬
‪−0.76‬
‪−0.79‬
‪−0.84‬
Surprise
−13.07%
+238.78%
−72.19%
+214.48%
+328.94%
+51.92%
+104.48%

Revenue

Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
‪0.00‬
‪‪25.00 M‬‬
‪‪50.00 M‬‬
‪‪75.00 M‬‬
‪‪100.00 M‬‬
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
‪‪18.17 M‬‬
‪‪43.73 M‬‬
‪‪41.85 M‬‬
‪‪59.12 M‬‬
‪‪94.69 M‬‬
‪‪19.57 M‬‬
‪‪37.40 M‬‬
Estimate
‪‪9.78 M‬‬
‪‪9.60 M‬‬
‪‪23.69 M‬‬
‪‪14.98 M‬‬
‪‪51.86 M‬‬
‪‪12.32 M‬‬
‪‪13.12 M‬‬
‪‪11.64 M‬‬
‪‪11.31 M‬‬
‪‪10.98 M‬‬
‪‪9.31 M‬‬
Surprise
+85.86%
+355.69%
+76.66%
+294.75%
+82.60%
+58.83%
+185.04%
Be warned

Frequently Asked Questions


TRDA EPS for the last quarter is 0.03 USD despite the estimation of −0.67 USD. In the next quarter EPS is expected to reach −0.73 USD. Track more of Entrada Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Entrada Therapeutics, Inc. revenue is expected to reach ‪11.64 M‬ USD. Check out Entrada Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, TRDA price target is 24.33 USD with a max estimate of 30.00 USD and a min estimate of 20.00 USD. Check if this forecast comes true in a year, meanwhile watch Entrada Therapeutics, Inc. stock price chart and keep track of the current situation with TRDA news and stock market news.
We've gathered opinions of 5 analysts rating TRDA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.